Potential therapeutic effect of olfactory ensheathing cells in neurological diseases: neurodegenerative diseases and peripheral nerve injuries

Front Immunol. 2023 Oct 17:14:1280186. doi: 10.3389/fimmu.2023.1280186. eCollection 2023.

Abstract

Neurological diseases are destructive, mainly characterized by the failure of endogenous repair, the inability to recover tissue damage, resulting in the increasing loss of cognitive and physical function. Although some clinical drugs can alleviate the progression of these diseases, but they lack therapeutic effect in repairing tissue injury and rebuilding neurological function. More and more studies have shown that cell therapy has made good achievements in the application of nerve injury. Olfactory ensheathing cells (OECs) are a special type of glial cells, which have been proved to play an important role as an alternative therapy for neurological diseases, opening up a new way for the treatment of neurological problems. The functional mechanisms of OECs in the treatment of neurological diseases include neuroprotection, immune regulation, axon regeneration, improvement of nerve injury microenvironment and myelin regeneration, which also include secreted bioactive factors. Therefore, it is of great significance to better understand the mechanism of OECs promoting functional improvement, and to recognize the implementation of these treatments and the effective simulation of nerve injury disorders. In this review, we discuss the function of OECs and their application value in the treatment of neurological diseases, and position OECs as a potential candidate strategy for the treatment of nervous system diseases.

Keywords: OECS; nerve regeneration; neurological diseases; role; treatment.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Axons / metabolism
  • Humans
  • Nerve Regeneration / physiology
  • Neurodegenerative Diseases* / metabolism
  • Neurodegenerative Diseases* / therapy
  • Olfactory Bulb
  • Peripheral Nerve Injuries* / metabolism
  • Peripheral Nerve Injuries* / therapy

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. These studies were supported by grants from the Natural Science Foundation of Jiangxi Province (20232BAB206048), Youth Science Foundation of Jiangxi Province (20224BAB216030).